(Presented at the 2012 International Workshop on HIV and Hepatitis Virus: Drug Resistance and Curative Strategies (IHDRW) in Sitges, Spain) Summary: This study evaluated the use of specimen types other than plasma for HCV diagnostic assays to eliminate logistical limitations and improve clinical management of patients on antiviral therapy in resource-limited settings.